ClinicalTrials.Veeva

Menu
C

Cardiology Consultants of Philadelphia | Yardley

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Apixaban
Vicadrostat
Naproxen
BI 690517
Ibuprofen
LY3298176
Rilonacept
Clopidogrel
Celecoxib
Inclisiran

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 19 total trials

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Active, not recruiting
Atrial Fibrillation
Drug: Apixaban Placebo
Drug: Milvexian

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these cond...

Enrolling
Hypertension
Cardiovascular Diseases
Drug: Placebo matching Vicadrostat
Drug: Vicadrostat

Trial sponsors

Boston Scientific logo
Abbott logo
Boehringer Ingelheim logo
Bristol-Myers Squibb (BMS) logo
C
Janssen (J&J Innovative Medicine) logo
K
Lilly logo
Novartis logo
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems